Henogen: Clinical Trials

6 completed, 1 withdrawn. 5 Phase 3, 2 Phase 2, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 3	5	Completed 5
Phase 2	2	Completed 1, Withdrawn 1
Phase 1	1	Withdrawn 1

Follow Henogen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease IT-Combination - Acute Graft Versus Host Disease	Phase 1 / Phase 2	Withdrawn	Henogen	12	2010-01-01	2009-04-29
Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule Adjuvanted Hepatitis B vaccine Lot 1, Adjuvanted Hepatitis B vaccine Lot 2, Adjuvanted Hep B vaccine Lot 3 - Hepatitis B	Phase 3	Completed	Henogen	450	2008-01-01	2008-08-25
Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™ Henogen HB vaccine, Fendrix vaccine - Hepatitis B	Phase 3	Completed	Henogen	102	2007-03-01	2009-11-19
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody. HB-AS02V vaccine, HBVAXPRO vaccine - Hepatitis B	Phase 3	Completed	Henogen	185	2006-03-01	2008-08-28
Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination HB-AS02V, HBVAXPRO vaccine - Hepatitis B	Phase 3	Completed	Henogen	257	2006-03-01	2008-08-28
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B. Henogen HBV vaccine, FENDRIX - Hepatitis B	Phase 3	Completed	Henogen	300	2006-02-01	2008-08-28
Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664). EBV vaccine (268664) - Epstein Barr Virus (EBV) Infection	Phase 2	Completed	Henogen	200		2007-02-02

Conditions studied

Hepatitis B (5)  ·  Epstein-Barr Virus Infections (1)  ·  Infections (1)  ·  Infectious Mononucleosis (1)

Interventions

Fendrix (1)

Countries

Belgium (5)  ·  Czechia (5)  ·  Hungary (4)  ·  Netherlands (1)

Top investigators

Christian Tielemans, MD, PhD (3)  ·  Anton V Schattenberg,, MD, PhD, (1)  ·  Jiri Beran, MD (1)

Results publications

PMID 18190254, PMID 20523113, PMID 21892006